
Layla Soroush
Examiner (ID: 14601, Phone: (571)272-5008 , Office: P/1627 )
| Most Active Art Unit | 1627 |
| Art Unit(s) | 1617, 1627, 1622 |
| Total Applications | 1222 |
| Issued Applications | 395 |
| Pending Applications | 172 |
| Abandoned Applications | 691 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16523707
[patent_doc_number] => 20200397787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => TREATMENT OF HAND ECZEMA
[patent_app_type] => utility
[patent_app_number] => 16/071209
[patent_app_country] => US
[patent_app_date] => 2017-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6081
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16071209
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/071209 | TREATMENT OF HAND ECZEMA | Jan 19, 2017 | Abandoned |
Array
(
[id] => 17712287
[patent_doc_number] => 11376266
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-05
[patent_title] => Antitumor agent
[patent_app_type] => utility
[patent_app_number] => 16/067906
[patent_app_country] => US
[patent_app_date] => 2017-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 3634
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16067906
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/067906 | Antitumor agent | Jan 4, 2017 | Issued |
Array
(
[id] => 13837117
[patent_doc_number] => 20190022043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-24
[patent_title] => METHODS OF USING CASPASE INHIBITORS IN TREATMENT OF LIVER DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/067497
[patent_app_country] => US
[patent_app_date] => 2016-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17158
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16067497
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/067497 | METHODS OF USING CASPASE INHIBITORS IN TREATMENT OF LIVER DISEASE | Dec 29, 2016 | Abandoned |
Array
(
[id] => 13774591
[patent_doc_number] => 20190000834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => INJECTABLE COMPOSITION AND A METHOD OF TREATMENT OF THE PHYSICAL ADDICTION
[patent_app_type] => utility
[patent_app_number] => 16/062840
[patent_app_country] => US
[patent_app_date] => 2016-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4897
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16062840
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/062840 | INJECTABLE COMPOSITION AND A METHOD OF TREATMENT OF THE PHYSICAL ADDICTION | Dec 15, 2016 | Abandoned |
Array
(
[id] => 13774617
[patent_doc_number] => 20190000847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => THERAPEUTIC AGENT FOR A WOUND
[patent_app_type] => utility
[patent_app_number] => 16/060643
[patent_app_country] => US
[patent_app_date] => 2016-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4402
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16060643
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/060643 | THERAPEUTIC AGENT FOR A WOUND | Dec 14, 2016 | Abandoned |
Array
(
[id] => 13618513
[patent_doc_number] => 20180360808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => VAP-1 INHIBITORS FOR TREATING PAIN
[patent_app_type] => utility
[patent_app_number] => 15/781936
[patent_app_country] => US
[patent_app_date] => 2016-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16725
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15781936
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/781936 | VAP-1 INHIBITORS FOR TREATING PAIN | Dec 6, 2016 | Abandoned |
Array
(
[id] => 13774503
[patent_doc_number] => 20190000790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => PPAR-GAMMA ACTIVATORS AND THEIR THERAPEUTICAL USAGES
[patent_app_type] => utility
[patent_app_number] => 15/780904
[patent_app_country] => US
[patent_app_date] => 2016-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4439
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15780904
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/780904 | PPAR-GAMMA ACTIVATORS AND THEIR THERAPEUTICAL USAGES | Nov 29, 2016 | Abandoned |
Array
(
[id] => 11954766
[patent_doc_number] => 20170258917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'SOLUBILITY OF THERAPEUTIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 15/341146
[patent_app_country] => US
[patent_app_date] => 2016-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8753
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15341146
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/341146 | Solubility of therapeutic agents | Nov 1, 2016 | Issued |
Array
(
[id] => 11441932
[patent_doc_number] => 20170042953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-16
[patent_title] => 'COMPOSITIONS AND METHODS FOR ENHANCING BRAIN FUNCTION USING ACETYL-L-CARNITINE, HUPERZINE A AND GINKGO BILOBA'
[patent_app_type] => utility
[patent_app_number] => 15/337221
[patent_app_country] => US
[patent_app_date] => 2016-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 22133
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15337221
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/337221 | Compositions and methods for enhancing brain function using acetyl-L-carnitine, huperzine A and ginkgo biloba | Oct 27, 2016 | Issued |
Array
(
[id] => 11441933
[patent_doc_number] => 20170042954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-16
[patent_title] => 'COMPOSITIONS AND METHODS FOR ENHANCING BRAIN FUNCTION USING ACETYL-L-CARNITINE, HUPERZINE A, GINKGO BILOBA, AND VITAMIN B COMPLEX'
[patent_app_type] => utility
[patent_app_number] => 15/337280
[patent_app_country] => US
[patent_app_date] => 2016-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 21943
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15337280
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/337280 | Compositions and methods for enhancing brain function using acetyl-L-carnitine, huperzine A, Ginkgo biloba, and vitamin B complex | Oct 27, 2016 | Issued |
Array
(
[id] => 18836725
[patent_doc_number] => 11844782
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-19
[patent_title] => Aqueous composition comprising dantrolene
[patent_app_type] => utility
[patent_app_number] => 15/952477
[patent_app_country] => US
[patent_app_date] => 2016-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 14
[patent_no_of_words] => 7123
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15952477
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/952477 | Aqueous composition comprising dantrolene | Oct 18, 2016 | Issued |
Array
(
[id] => 11601728
[patent_doc_number] => 20170119027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'SYSTEM FOR REDUCING BACTERIA ON FOOD SURFACES WHILE EXTENDING SHELF LIFE'
[patent_app_type] => utility
[patent_app_number] => 15/293135
[patent_app_country] => US
[patent_app_date] => 2016-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3599
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15293135
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/293135 | SYSTEM FOR REDUCING BACTERIA ON FOOD SURFACES WHILE EXTENDING SHELF LIFE | Oct 12, 2016 | Abandoned |
Array
(
[id] => 13590821
[patent_doc_number] => 20180346959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => Methods of Prediction of Wound Healing
[patent_app_type] => utility
[patent_app_number] => 15/761546
[patent_app_country] => US
[patent_app_date] => 2016-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8603
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15761546
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/761546 | Methods of prediction of wound healing | Sep 25, 2016 | Issued |
Array
(
[id] => 11381513
[patent_doc_number] => 20170007570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-12
[patent_title] => 'PREPARATIONS OF TAXANES FOR INTRAVENOUS ADMINISTRATION AND THE PREPARATION METHOD THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/274452
[patent_app_country] => US
[patent_app_date] => 2016-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8477
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15274452
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/274452 | PREPARATIONS OF TAXANES FOR INTRAVENOUS ADMINISTRATION AND THE PREPARATION METHOD THEREOF | Sep 22, 2016 | Abandoned |
Array
(
[id] => 13603903
[patent_doc_number] => 20180353500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-13
[patent_title] => ADMINISTRATION OF DEUTERATED CFTR POTENTIATORS
[patent_app_type] => utility
[patent_app_number] => 15/761532
[patent_app_country] => US
[patent_app_date] => 2016-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9646
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15761532
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/761532 | ADMINISTRATION OF DEUTERATED CFTR POTENTIATORS | Sep 20, 2016 | Abandoned |
Array
(
[id] => 16335633
[patent_doc_number] => 10786571
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-29
[patent_title] => Hydrophilic gel for topical delivery of 5-aminolevulinic acid
[patent_app_type] => utility
[patent_app_number] => 15/761623
[patent_app_country] => US
[patent_app_date] => 2016-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4867
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15761623
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/761623 | Hydrophilic gel for topical delivery of 5-aminolevulinic acid | Sep 19, 2016 | Issued |
Array
(
[id] => 13410117
[patent_doc_number] => 20180256601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-13
[patent_title] => URSODEOXYCHOLIC ACID AND BRAIN DISORDERS
[patent_app_type] => utility
[patent_app_number] => 15/760080
[patent_app_country] => US
[patent_app_date] => 2016-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14992
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15760080
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/760080 | URSODEOXYCHOLIC ACID AND BRAIN DISORDERS | Sep 15, 2016 | Abandoned |
Array
(
[id] => 13397455
[patent_doc_number] => 20180250270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-06
[patent_title] => MUSCARINIC COMBINATION AND ITS USE FOR COMBATING HYPOCHOLINERGIC DISORDERS OF THE CENTRAL NERVOUS SYSTEM
[patent_app_type] => utility
[patent_app_number] => 15/756639
[patent_app_country] => US
[patent_app_date] => 2016-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26014
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15756639
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/756639 | MUSCARINIC COMBINATION AND ITS USE FOR COMBATING HYPOCHOLINERGIC DISORDERS OF THE CENTRAL NERVOUS SYSTEM | Sep 8, 2016 | Abandoned |
Array
(
[id] => 13397533
[patent_doc_number] => 20180250309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-06
[patent_title] => METHODS FOR TREATMENT OF MONOCYTE DYSFUNCTION AND CHRONIC INFLAMMATORY MICRO AND MACRO-VASCULAR DISEASES
[patent_app_type] => utility
[patent_app_number] => 15/757266
[patent_app_country] => US
[patent_app_date] => 2016-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7581
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15757266
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/757266 | METHODS FOR TREATMENT OF MONOCYTE DYSFUNCTION AND CHRONIC INFLAMMATORY MICRO AND MACRO-VASCULAR DISEASES | Sep 4, 2016 | Pending |
Array
(
[id] => 13410185
[patent_doc_number] => 20180256635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-13
[patent_title] => LAXATIVE FORMULATIONS AND MANUFACTURE
[patent_app_type] => utility
[patent_app_number] => 15/756922
[patent_app_country] => US
[patent_app_date] => 2016-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4558
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -82
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15756922
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/756922 | LAXATIVE FORMULATIONS AND MANUFACTURE | Aug 31, 2016 | Abandoned |